Literature DB >> 15548792

Uveitis and neurological diseases.

L K Gordon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548792      PMCID: PMC1772417          DOI: 10.1136/bjo.2004.051797

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  11 in total

Review 1.  Manipulating dendritic cell biology for the active immunotherapy of cancer.

Authors:  David W O'Neill; Sylvia Adams; Nina Bhardwaj
Journal:  Blood       Date:  2004-07-01       Impact factor: 22.113

Review 2.  Bench to bedside: new approaches to the immunotherapy of uveitic disease.

Authors:  Robert B Nussenblatt
Journal:  Int Rev Immunol       Date:  2002 Mar-Jun       Impact factor: 5.311

3.  Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus.

Authors:  R D Levinson; R Vann; J L Davis; D N Friedberg; A Tufail; B T Terry; J I Lindley; G N Holland
Journal:  Am J Ophthalmol       Date:  1998-03       Impact factor: 5.258

Review 4.  Uveitis: role of the physician in treating systemic causes.

Authors:  J P Dunn; R A Nozik
Journal:  Geriatrics       Date:  1994-08

Review 5.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

Review 6.  Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

Authors:  Heinz Wiendl; Reinhard Hohlfeld
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 7.  Diagnosing the systemic associations of anterior uveitis.

Authors:  J R Smith; D J Coster
Journal:  Aust N Z J Ophthalmol       Date:  1998-11

Review 8.  Using antibodies in tumour immunotherapy.

Authors:  Birgit C Schultes; Christopher F Nicodemus
Journal:  Expert Opin Biol Ther       Date:  2004-08       Impact factor: 4.388

Review 9.  The immune tolerance network: a new paradigm for developing tolerance-inducing therapies.

Authors:  Daniel Rotrosen; Jeff B Matthews; Jeffrey A Bluestone
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793

10.  Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.

Authors:  Kathrin Greiner; Conor C Murphy; Francois Willermain; Linda Duncan; Jarka Plskova; Geoff Hale; John D Isaacs; John V Forrester; Andrew D Dick
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

View more
  2 in total

1.  Eye disorders in patients with multiple sclerosis: natural history and management.

Authors:  Jennifer Graves; Laura J Balcer
Journal:  Clin Ophthalmol       Date:  2010-12-06

Review 2.  Gender and uveitis in patients with multiple sclerosis.

Authors:  Lynn K Gordon; Debra A Goldstein
Journal:  J Ophthalmol       Date:  2014-05-07       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.